Fujimoto Katsunada, Harada Taishi, Watanabe Kentaro
Fourth Department of Internal Medicine, Division of Respiratory Medicine, Fukuoka University School of Medicine.
Nihon Ronen Igakkai Zasshi. 2005 Jul;42(4):453-6. doi: 10.3143/geriatrics.42.453.
An 82-year-old man with extensive small cell lung cancer was treated with 2 courses of low dose CPT-11 (40 mg/body, day 1, 8 and 15) and carboplatin (100 mg/body, day 1). The reduction in tumor sizes evaluated by two-direction measurement was 88%. His creatinine clearance rates before and after chemotherapy were 20 and 28 ml/min, respectively. Temporary leukopenia (900/microl) during the second course of chemotherapy was quickly reversed by the administration of G-CSF, without any episode of infection. Low dose CPT-11 and carboplatin seems to be a promising regimen for elderly patients with small cell lung cancer and renal dysfunction. Cancer tends to increase in old age groups. We consider that it is necessary to examine ideal low dose chemotherapies that can be effective yet preserve quality of life.
一名82岁广泛期小细胞肺癌男性患者接受了2个疗程的低剂量伊立替康(40mg/体,第1、8和15天)及卡铂(100mg/体,第1天)治疗。通过双向测量评估的肿瘤大小缩小率为88%。化疗前后他的肌酐清除率分别为20和28ml/分钟。化疗第二个疗程期间出现的短暂白细胞减少(900/微升)通过给予粒细胞集落刺激因子迅速得到纠正,未发生任何感染事件。低剂量伊立替康和卡铂似乎是老年小细胞肺癌合并肾功能不全患者的一种有前景的治疗方案。癌症在老年人群中趋于增加。我们认为有必要研究既有效又能保留生活质量的理想低剂量化疗方案。